NextCure, Inc. Share Price
NXTCNextCure, Inc. Stock Performance
Open $5.91 | Prev. Close $6.13 | Circuit Range N/A |
Day Range $5.71 - $6.37 | Year Range $1.55 - $15.61 | Volume 12,871 |
Average Traded $5.90 |
NextCure, Inc. Share Price Chart
About NextCure, Inc.
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NextCure, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Jul-26 | $5.91 | $6.00 | -4.31% |
16-Jul-26 | $6.75 | $6.27 | -3.54% |
15-Jul-26 | $5.54 | $6.50 | -0.46% |
14-Jul-26 | $9.23 | $6.53 | +186.40% |
13-Jul-26 | $1.96 | $2.28 | +16.92% |
10-Jul-26 | $1.96 | $1.95 | -5.80% |
09-Jul-26 | $1.80 | $2.07 | +18.97% |
FAQs on NextCure, Inc. Share Price
Can I buy NextCure, Inc. shares in India?
What is the share price of NextCure, Inc.?
What is the 5 year returns of NextCure, Inc.?
What are the high & low stock price of NextCure, Inc. today?
What is the 52-week high and low of NextCure, Inc. stock?